260 related articles for article (PubMed ID: 31810401)
1. Cellular distribution of PACAP-38 and PACAP receptors in the rat brain: Relation to migraine activated regions.
Warfvinge K; Edvinsson L
Cephalalgia; 2020 May; 40(6):527-542. PubMed ID: 31810401
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine.
Zhang Q; Han X; Wu H; Zhang M; Hu G; Dong Z; Yu S
Mol Pain; 2019; 15():1744806918820452. PubMed ID: 30799680
[TBL] [Abstract][Full Text] [Related]
3. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
4. Temporal alterations of pituitary adenylate cyclase activating polypeptide and its receptors in a rat model induced by recurrent chemical stimulations: Relevant to chronic migraine.
Wu H; Dong Z; Liu Y; Zhang Q; Zhang M; Hu G; Yu S; Han X
Mol Pain; 2023; 19():17448069231152129. PubMed ID: 36604785
[No Abstract] [Full Text] [Related]
5. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
6. Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans.
Frederiksen SD; Warfvinge K; Ohlsson L; Edvinsson L
Neuroscience; 2018 Nov; 393():319-332. PubMed ID: 30336190
[TBL] [Abstract][Full Text] [Related]
7. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
[TBL] [Abstract][Full Text] [Related]
8. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
9. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development.
Basille M; Vaudry D; Coulouarn Y; Jegou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez B
J Comp Neurol; 2000 Oct; 425(4):495-509. PubMed ID: 10975876
[TBL] [Abstract][Full Text] [Related]
10. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
Joo KM; Chung YH; Kim MK; Nam RH; Lee BL; Lee KH; Cha CI
J Comp Neurol; 2004 Aug; 476(4):388-413. PubMed ID: 15282712
[TBL] [Abstract][Full Text] [Related]
11. PAC
Tasma Z; Siow A; Harris PWR; Brimble MA; O'Carroll SJ; Hay DL; Walker CS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430275
[TBL] [Abstract][Full Text] [Related]
12. Discovery of PACAP and its receptors in the brain.
Hirabayashi T; Nakamachi T; Shioda S
J Headache Pain; 2018 Apr; 19(1):28. PubMed ID: 29619773
[TBL] [Abstract][Full Text] [Related]
13. Localization of the neuropeptides pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and their receptors in the basal brain blood vessels and trigeminal ganglion of the mouse CNS; an immunohistochemical study.
Lund AM; Hannibal J
Front Neuroanat; 2022; 16():991403. PubMed ID: 36387999
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of agonist signalling profiles and agonist-dependent antagonism at PACAP-responsive receptors: Implications for drug discovery.
Tasma Z; Siow A; Harris PWR; Brimble MA; Hay DL; Walker CS
Br J Pharmacol; 2022 Feb; 179(3):435-453. PubMed ID: 34612509
[TBL] [Abstract][Full Text] [Related]
15. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
[TBL] [Abstract][Full Text] [Related]
16. PACAP and its role in primary headaches.
Edvinsson L; Tajti J; Szalárdy L; Vécsei L
J Headache Pain; 2018 Mar; 19(1):21. PubMed ID: 29523978
[TBL] [Abstract][Full Text] [Related]
17. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].
Hashimoto H
Yakugaku Zasshi; 2002 Dec; 122(12):1109-21. PubMed ID: 12510388
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of PACAP receptors in postnatal rat brain.
Shneider Y; Shtrauss Y; Yadid G; Pinhasov A
Neuropeptides; 2010 Dec; 44(6):509-14. PubMed ID: 20971507
[TBL] [Abstract][Full Text] [Related]
20. PACAP and its receptors in cranial arteries and mast cells.
Jansen-Olesen I; Hougaard Pedersen S
J Headache Pain; 2018 Feb; 19(1):16. PubMed ID: 29460121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
